|
Lee, P. C. (2003). Innovation as a behavioural response to environmental challenges. In S. M. Reader and K. N. Laland (Ed.), Animal Innovation (pp. 261–279). Oxford: Oxford University Press.
|
|
Laland, K. N., & van Bergen, Y. (2003). Experimental studies of innovation in the guppy. Animal Innovation, , 155–174.
|
|
Greenberg, R. (2003). The role of neophobia and neophilia in the development of innovative behavour in birds. In S. M. Reader and K. N. Laland (Ed.), Animal Innovation. Oxford: Oxford University Press.
|
|
Reader, S. M., & MacDonald, K. (2003). Environmental variability and primate behavioural flexibiity. In S. M. Reader, & K. L. Laland (Eds.), Animal Innovation (pp. 83–116). Oxford: Oxford University Press.
|
Young, R. J. (2003). Environmental Enrichment for Captive Animals.
Abstract: Environmental enrichment is a simple and effective means of improving animal welfare in any species – companion, farm, laboratory and zoo. For many years, it has been a popular area of research, and has attracted the attention and concerns of animal keepers and carers, animal industry professionals, academics, students and pet owners all over the world.
|
|
Haidn, B., & Berger, N. (2003). Arbeitszeitbedarf für die Pensionspferdehaltung in landwirt-schaftlichen Betrieben. Tagungsband 6, Vechta 25.-27. März 2003, Tagung: Bau, Technik und Umwelt in der landwirtsch, 386–391.
|
Nelson, E. E., Shelton, S. E., & Kalin, N. H. (2003). Individual differences in the responses of naive rhesus monkeys to snakes. Emotion, 3(1), 3–11.
Abstract: The authors demonstrated individual differences in inhibited behavior and withdrawal responses of laboratory-born rhesus monkeys when initially exposed to a snake. Most monkeys displayed a small significant increase in their behavioral inhibition in the presence of a snake. A few monkeys had marked responses, and some actively withdrew. Although the responses of the most extreme laboratory-born monkeys were comparable to feral-born monkeys, the responses of the laboratory-born monkeys rapidly habituated. The individual differences in the responses of naive monkeys likely reflect a continuum from orienting to wariness to fear. A neurobiological model is presented that addresses potential mechanisms underlying these individual differences, their relation to fear, and how they may predispose to phobia development.
|
Dirikolu, L., Lehner, A. F., Karpiesiuk, W., Hughes, C., Woods, W. E., Boyles, J., et al. (2003). Detection, quantification, metabolism, and behavioral effects of selegiline in horses. Vet Ther, 4(3), 257–268.
Abstract: Selegiline ([R]-[-]N,alpha-dimethyl-N-2- propynylphenethylamine or l-deprenyl), an irreversible inhibitor of monoamine oxidase, is a classic antidyskinetic and antiparkinsonian agent widely used in human medicine both as monotherapy and as an adjunct to levodopa therapy. Selegiline is classified by the Association of Racing Commissioners International (ARCI) as a class 2 agent, and is considered to have high abuse potential in racing horses. A highly sensitive LC/MS/MS quantitative analytical method has been developed for selegiline and its potential metabolites amphetamine and methamphetamine using commercially available deuterated analogs of these compounds as internal standards. After administering 40 mg of selegiline orally to two horses, relatively low (<60 ng/ml) concentrations of parent selegiline, amphetamine, and methamphetamine were recovered in urine samples. However, relatively high urinary concentrations of another selegiline metabolite were found, tentatively identified as N- desmethylselegiline. This metabolite was synthesized and found to be indistinguishable from the new metabolite recovered from horse urine, thereby confirming the chemical identity of the equine metabolite. Additionally, analysis of urine samples from four horses dosed with 50 mg of selegiline confirmed that N-desmethylselegiline is the major urinary metabolite of selegiline in horses. In related behavior studies, p.o. and i.v. administration of 30 mg of selegiline produced no significant changes in either locomotor activities or heart rates.
|
Natalini, C. C., & Robinson, E. P. (2003). Effects of epidural opioid analgesics on heart rate, arterial blood pressure, respiratory rate, body temperature, and behavior in horses. Vet Ther, 4(4), 364–375.
Abstract: Heart rate, arterial blood pressures, respiratory rate, body temperature, and central nervous system excitement were compared before and after epidural administration of morphine (0.1 mg/kg), butorphanol (0.08 mg/kg), alfentanil (0.02 mg/kg), tramadol (1.0 mg/kg), the k-opioid agonist U50488H (0.08 mg/kg), or sterile water using an incomplete Latin square crossover design in five conscious adult horses. Treatments were administered into the first intercoccygeal epidural space. Significant (P <.05) reductions in respiratory rate were detected after epidural administration of morphine, alfentanil, U50488H, and sterile water. Additionally, significant (P <.05) head ptosis was observed within the first hour after administration of morphine, U50488H, and tramadol, but neither of these changes appeared to be of clinical significance. No treatment-related changes in motor activity or behavior were observed.
|
Adolphs, R. (2003). Cognitive neuroscience of human social behaviour. Nat Rev Neurosci, 4(3), 165–178.
Abstract: We are an intensely social species--it has been argued that our social nature defines what makes us human, what makes us conscious or what gave us our large brains. As a new field, the social brain sciences are probing the neural underpinnings of social behaviour and have produced a banquet of data that are both tantalizing and deeply puzzling. We are finding new links between emotion and reason, between action and perception, and between representations of other people and ourselves. No less important are the links that are also being established across disciplines to understand social behaviour, as neuroscientists, social psychologists, anthropologists, ethologists and philosophers forge new collaborations.
|
